Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126949911 | 12694991 | 1 | I | 20160823 | 20160829 | 20160829 | EXP | US-MYLANLABS-2016M1036147 | MYLAN | MILKS KS, MCLEAN TW, ANTHONY EY. IMAGING OF PRIMARY PEDIATRIC LYMPHOMA OF BONE. PEDIATR-RADIOL 2016;46(8):1150-1157. | 0.00 | Y | 0.00000 | 20160829 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126949911 | 12694991 | 1 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 2 | PS | CYTARABINE. | CYTARABINE | 1 | Unknown | U | U | 200914 | |||||||||
| 126949911 | 12694991 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 6 | SS | DAUNORUBICIN | DAUNORUBICIN | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 7 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 8 | SS | PEGASPARGASE | PEGASPARGASE | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | U | 0 | |||||||||
| 126949911 | 12694991 | 10 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126949911 | 12694991 | 1 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 2 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 3 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 4 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 5 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 6 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 7 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 8 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 9 | Non-Hodgkin's lymphoma |
| 126949911 | 12694991 | 10 | Non-Hodgkin's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126949911 | 12694991 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126949911 | 12694991 | Osteonecrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |